RELENZA

Product Overview

About RELENZA

RELENZA is a medication that contains the active ingredient ZANAMIVIR, used for the treatment and prevention of influenza caused by virus types A and B. It belongs to a class of drugs known as neuraminidase inhibitors, which work by stopping the spread of the flu virus in the body. RELENZA is administered via inhalation, providing a targeted approach to treating respiratory infections.

Key Benefits & Uses

• Treatment of influenza A and B in patients 7 years and older
• Prevention of influenza A and B in patients 5 years and older
• Reduces the duration and severity of flu symptoms, such as fever, cough, sore throat, and body aches

Active Ingredient & Action

ZANAMIVIR, the active ingredient in RELENZA, works by inhibiting the neuraminidase enzyme on the surface of the influenza virus. This enzyme is essential for the release of new viral particles from infected cells. By blocking neuraminidase, ZANAMIVIR prevents the virus from spreading to other cells, thereby reducing the severity and duration of flu symptoms.

Important Notes

It is essential to use RELENZA under the guidance of a healthcare professional, especially in patients with underlying respiratory conditions such as asthma or chronic obstructive pulmonary disease (COPD). Patients should follow the recommended dosage and administration instructions carefully to ensure safe and effective use of RELENZA.